Search
Search Results
##search.searchResults.foundPlural##
-
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2677PDF: 1426HTML: 1872CoverLetter: 235 -
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
103PDF: 40Suppl. Files: 13Html: 27Html Suppl. Files: 7 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1955PDF: 995HTML: 1039Referring article: 802 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1294PDF: 1198HTML: 529 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
176PDF: 137Suppl. Files: 28Html: 31Html Suppl. Files: 23 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4508PDF: 1475HTML: 2213 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1672PDF: 893Suppl. Files: 376Html: 179 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1742PDF: 842HTML: 4433Figure 1: 199Untitled: 190Untitled: 246 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3680PDF: 984HTML: 1708figure 1: 209Untitled: 239 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2544PDF: 1090HTML: 1680Fig 1: 271Tab I: 263Cover Letter: 273 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1649PDF: 998Suppl. Files: 499HTML: 310 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3455PDF: 1974HTML: 3740 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1292PDF: 827HTML: 1551Figure 1: 274Figure 2: 294 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1602PDF: 579HTML: 364 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4808PDF: 3960HTML: 383 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3378PDF: 1508HTML: 14038jdoe, Dening.MarijuanaFi7.doc: 247jdoe, Dening.MarijuanaFi6.doc: 235jdoe, Dening.MarijuanaFi5.doc: 224jdoe, Dening.MarijuanaFi4.doc: 238jdoe, Dening.MarijuanaFi3.doc: 246jdoe, Dening.MarijuanaFi2.doc: 296jdoe, Dening.MarijuanaFig1.doc: 263 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4587PDF: 1002HTML: 1376Table1: 290 -
CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB
1977PDF: 762HTML: 247 -
An unusual cause of anemia and encephalopathy
4250PDF: 946HTML: 1557 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2131PDF: 876HTML: 675 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2338PDF: 918HTML: 272 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2729PDF: 1839HTML: 738 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1466PDF: 1147HTML: 479 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3637PDF: 884HTML: 3039Figure 1a and 1b: 213Figure 2: 224Figure 3: 218Figure 4: 211Figure 5: 207Tables 1-5: 185 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1321PDF: 656HTML: 6943 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2156PDF: 2045HTML: 813







